Latest filing published 23 Feb 2015 for Kiora Pharmaceuticals INC.
Insider track record
No signal scores available.
Private Equity Natixis: trading record in brief
All filings by Private Equity Natixis on record concern Kiora Pharmaceuticals Inc. Altogether 2 filings, all relating to 19 February 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 23 February 2015 with a transaction in Kiora Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Private Equity Natixis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 576,564 sharesCommon StockSEC:0001144204-15-011502:0
- 97,641 shares@ US$4.20Common StockSEC:0001144204-15-011502:1
2 of 2 declarations